Results 101 to 110 of about 243,764 (341)

Administration of Long-Acting Injections [PDF]

, 2018
Expanding the scope of pharmacy practice demonstrates that the profession has been successful at improving public health. Despite being a late adopter, New York\u27s limited experience with vaccines has improved immunization rates and lowered rates of ...
Noel, Christopher, Williams, Karl
core   +1 more source

Minimal-medication approaches to treating schizophrenia [PDF]

, 2009
UK guidelines for treating people diagnosed with schizo phrenia currently emphasise the primacy of antipsychotic medication, with or without psycho-socially based interventions as circumstances dictate.
Aderhold, Agar-Jacomb, Barnes, Bennett, Burston, Calton, Carpenter, Ciompi, Ciompi, Cooper, Davis, Day, Descartes, Digby, Fins, Fulford, Gray, Griesinger, Grisso, Harrow, Helen Spandler, Hogarty, Hyman, Loebel, Mosher, Mosher, Mosher, Pasamanick, Pincus, Podvoll, Porter, Pullen, Rappaport, Rose, Seikkula, Seikkula, Statsny, Tim Calton, Warner, Watkins, Wirt   +40 more
core   +1 more source

The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

BMC Psychiatry, 2018
Background Metabolic abnormalities are common in patients maintained on antipsychotics. These abnormalities increase the risk of cardiovascular diseases and mortality in this population.
Samer Hammoudeh, Suhaila Ghuloum, Ziyad Mahfoud, Arij Yehya, Abdulmoneim Abdulhakam, Azza Al-Mujalli, Mahmoud Al-Zirie, Mohamed Osman Abdel Rahman, Angela Godwin, Noura Younes, Yahya Hani, Dennis Mook-Kanamori, Marjonneke Mook-Kanamori, Reem El Sherbiny, Hassen Al-Amin   +14 more
doaj   +1 more source

Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?

Lipids in Health and Disease, 2020
Antipsychotic-induced weight gain is the most prevalent somatic adverse event occurring in patients treated by antipsychotics, especially atypical antipsychotics.
Francky Teddy Endomba, Aurel T. Tankeu, Jan René Nkeck, Joel Noutakdie Tochie   +3 more
doaj   +1 more source

Paediatric developmental safety and the ICH E11A extrapolation of safety

British Journal of Clinical Pharmacology, EarlyView.
Gilbert J. Burckart, Susan M. Abdel‐Rahman, Gelareh Abulwerdi, Rebecca Racz, Sherbet Samuels, Dionna J. Green, Lynne P. Yao   +6 more
wiley   +1 more source

Faecal Microbiota Transplantation in Anorexia Nervosa: A Systematic Review of Methodologies, Outcomes, and Challenges With Recommendations for Future Studies

European Eating Disorders Review, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder displaying an altered gut microbiome. Faecal microbiome transplantation (FMT) has emerged as a powerful research tool and potential treatment option in AN due to the microbiome‐gut‐brain axis. Current studies are limited and reveal variable FMT protocols.
Anna C. Thelen, Nele M. Korten, Larissa Blischke, Clara Voelz, Cordian Beyer, Jochen Seitz, Stefanie Trinh   +6 more
wiley   +1 more source

The pharmacist’s response to the needs of patients undergoing treatment with psychotropic medication [PDF]

, 1999
The usage of psychotropic (Table 1) medication is considerable world wide. In Malta, this can be attested to by the numerous studies that have been conducted by the University of Malta Department of Pharmacy (in conjuction with other institutions and ...
Sant Fournier, Mary Ann
core  

Automated identification of Fos expression [PDF]

, 2001
The concentration of Fos, a protein encoded by the immediate-early gene c-fos, provides a measure of synaptic activity that may not parallel the electrical activity of neurons.
Cherkerzian, S., Cohen, B.M., Ennulat, D.J., Evans, M.L., Froimowitz, M.P., Lange, N., Ma, J., Young, D.   +7 more
core   +1 more source

Second-generation antipsychotics and metabolic syndrome: a role for mitochondria [PDF]

, 2023
Katherine R. H. Mortimer, Mohammed Zia Ul Haq Katshu, Lisa Chakrabarti   +2 more
openalex   +1 more source

Comparison of relapse rates of depot and oral antipsychotics in patients with schizophrenia [PDF]

, 2017
Introduction: Antipsychotics are the mainstay of treatment in schizophrenia. First-generation and second-generation antipsychotics are available as oral and depot formulations.
Ball, Patrick, Mahesh, K H D, Morrissey, Hana, Subasinghe H.W.A.S, Weerasundera,R   +4 more
core   +1 more source